These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24880687)

  • 1. Structures of HIV-1 RT-RNA/DNA ternary complexes with dATP and nevirapine reveal conformational flexibility of RNA/DNA: insights into requirements for RNase H cleavage.
    Das K; Martinez SE; Bandwar RP; Arnold E
    Nucleic Acids Res; 2014 Jul; 42(12):8125-37. PubMed ID: 24880687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N348I in HIV-1 reverse transcriptase can counteract the nevirapine-mediated bias toward RNase H cleavage during plus-strand initiation.
    Biondi MJ; Beilhartz GL; McCormick S; Götte M
    J Biol Chem; 2010 Aug; 285(35):26966-26975. PubMed ID: 20530477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine.
    Schuckmann MM; Marchand B; Hachiya A; Kodama EN; Kirby KA; Singh K; Sarafianos SG
    J Biol Chem; 2010 Dec; 285(49):38700-9. PubMed ID: 20876531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism.
    Das K; Martinez SE; Bauman JD; Arnold E
    Nat Struct Mol Biol; 2012 Jan; 19(2):253-9. PubMed ID: 22266819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of HIV-1 reverse transcriptase cleaving RNA in an RNA/DNA hybrid.
    Tian L; Kim MS; Li H; Wang J; Yang W
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):507-512. PubMed ID: 29295939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication.
    Li TK; Barbieri CM; Lin HC; Rabson AB; Yang G; Fan Y; Gaffney BL; Jones RA; Pilch DS
    Biochemistry; 2004 Aug; 43(30):9732-42. PubMed ID: 15274628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics study of HIV-1 RT-DNA-nevirapine complexes explains NNRTI inhibition and resistance by connection mutations.
    Vijayan RS; Arnold E; Das K
    Proteins; 2014 May; 82(5):815-29. PubMed ID: 24174331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
    Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
    Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 reverse transcriptase-catalyzed DNA strand transfer reactions by 4-chlorophenylhydrazone of mesoxalic acid.
    Davis WR; Tomsho J; Nikam S; Cook EM; Somand D; Peliska JA
    Biochemistry; 2000 Nov; 39(46):14279-91. PubMed ID: 11087377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 reverse transcriptase and antiviral drug resistance. Part 2.
    Das K; Arnold E
    Curr Opin Virol; 2013 Apr; 3(2):119-28. PubMed ID: 23602470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slide into action: dynamic shuttling of HIV reverse transcriptase on nucleic acid substrates.
    Liu S; Abbondanzieri EA; Rausch JW; Le Grice SF; Zhuang X
    Science; 2008 Nov; 322(5904):1092-7. PubMed ID: 19008444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of an eight-base pair duplex containing the 3'-DNA-RNA-5' junction formed during initiation of minus-strand synthesis of HIV replication.
    Mueller U; Maier G; Mochi Onori A; Cellai L; Heumann H; Heinemann U
    Biochemistry; 1998 Sep; 37(35):12005-11. PubMed ID: 9724510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mutations in the polymerase domain on the polymerase, RNase H and strand transfer activities of human immunodeficiency virus type 1 reverse transcriptase.
    Gao HQ; Boyer PL; Arnold E; Hughes SH
    J Mol Biol; 1998 Apr; 277(3):559-72. PubMed ID: 9533880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.
    Boyer PL; Smith SJ; Zhao XZ; Das K; Gruber K; Arnold E; Burke TR; Hughes SH
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
    Gao HQ; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site.
    Sarafianos SG; Das K; Ding J; Boyer PL; Hughes SH; Arnold E
    Chem Biol; 1999 May; 6(5):R137-46. PubMed ID: 10322129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing.
    Driscoll MD; Golinelli MP; Hughes SH
    J Virol; 2001 Jan; 75(2):672-86. PubMed ID: 11134281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantum computational analysis for drug resistance of HIV-1 reverse transcriptase to nevirapine through point mutations.
    He X; Mei Y; Xiang Y; Zhang DW; Zhang JZ
    Proteins; 2005 Nov; 61(2):423-32. PubMed ID: 16114038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights into mechanisms of non-nucleoside drug resistance for HIV-1 reverse transcriptases mutated at codons 101 or 138.
    Ren J; Nichols CE; Stamp A; Chamberlain PP; Ferris R; Weaver KL; Short SA; Stammers DK
    FEBS J; 2006 Aug; 273(16):3850-60. PubMed ID: 16911530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contacts between reverse transcriptase and the primer strand govern the transition from initiation to elongation of HIV-1 reverse transcription.
    Lanchy JM; Keith G; Le Grice SF; Ehresmann B; Ehresmann C; Marquet R
    J Biol Chem; 1998 Sep; 273(38):24425-32. PubMed ID: 9733733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.